Genmab Research Development from 2010 to 2026
| GE9 Stock | EUR 280.00 1.20 0.43% |
Research Development | First Reported 2010-12-31 | Previous Quarter 2.7 B | Current Value 2.9 B | Quarterly Volatility 970.7 M |
Check Genmab A/S financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genmab A/S's main balance sheet or income statement drivers, such as Discontinued Operations of 33.8 M, Interest Expense of 0.0 or Selling General Administrative of 413 M, as well as many indicators such as Price To Sales Ratio of 4.9, Dividend Yield of 0.0 or PTB Ratio of 2.25. Genmab financial statements analysis is a perfect complement when working with Genmab A/S Valuation or Volatility modules.
Genmab | Research Development |
The Research Development trend for Genmab AS offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Genmab A/S is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Genmab A/S's Research Development Growth Pattern
Below is the plot of the Research Development of Genmab AS over the last few years. It is Genmab A/S's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Genmab A/S's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Genmab Research Development Regression Statistics
| Arithmetic Mean | 1,528,739,235 | |
| Geometric Mean | 1,200,849,416 | |
| Coefficient Of Variation | 63.50 | |
| Mean Deviation | 907,186,014 | |
| Median | 1,431,000,000 | |
| Standard Deviation | 970,673,547 | |
| Sample Variance | 942207.1T | |
| Range | 2.4B | |
| R-Value | 0.93 | |
| Mean Square Error | 134613T | |
| R-Squared | 0.87 | |
| Slope | 178,886,252 | |
| Total Sum of Squares | 15075314.2T |
Genmab Research Development History
About Genmab A/S Financial Statements
Genmab A/S stakeholders use historical fundamental indicators, such as Genmab A/S's Research Development, to determine how well the company is positioned to perform in the future. Although Genmab A/S investors may analyze each financial statement separately, they are all interrelated. For example, changes in Genmab A/S's assets and liabilities are reflected in the revenues and expenses on Genmab A/S's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Genmab AS. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 2.7 B | 2.9 B |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Genmab A/S Correlation against competitors. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.